Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists.
In conclusion, long-term treatment with budesonide/formoterol was associated with lower rates of sepsis and deaths than fluticasone/salmeterol in patients with COPD.
PMID: 31509517 [PubMed - as supplied by publisher]
Source: Aging - Category: Biomedical Science Authors: Wang CY, Lin YS, Wang YH, Lai CC, Wang HC, Chen L, Yu CJ, Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) Tags: Aging (Albany NY) Source Type: research
More News: Advair | Biomedical Science | Chronic Obstructive Pulmonary | Clinical Trials | Corticosteroid Therapy | Databases & Libraries | Flonase | Health Insurance | Insurance | Respiratory Medicine | Septic Shock | Skin | Study | Symbicort | Taiwan Health